We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $717B
1-Year Est. Return 35.42%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+35.42%
3 Year Est. Return
+133.7%
5 Year Est. Return
+183.13%
10 Year Est. Return
+734.77%
AUM
$295B
AUM Growth
+$5.66B
Cap. Flow
-$1.6B
Cap. Flow %
-0.54%
Top 10 Hldgs %
26.08%
Holding
466
New
25
Increased
139
Reduced
121
Closed
25

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.53B
2
AAPL icon
Apple
AAPL
+$2.36B
3
BIIB icon
Biogen
BIIB
+$1.67B
4
GS icon
Goldman Sachs
GS
+$1.11B
5
BRCM
BROADCOM CORP CL-A
BRCM
+$1.06B

Sector Composition

Rank Sector Weight
1 Healthcare 21.03%
2 Technology 12.36%
3 Industrials 11.39%
4 Communication Services 10.61%
5 Consumer Staples 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLTC
201
DELISTED
Linear Technology Corp
LLTC
$283M 0.1%
6,210,000
CAT icon
202
Caterpillar
CAT
$393B
$282M 0.1%
3,085,400
-4,983,633
-62% -$485M
IBM icon
203
IBM
IBM
$222B
$278M 0.09%
1,809,257
-418,400
-19% -$66.6M
IOC
204
DELISTED
Interoil Corporation
IOC
$270M 0.09%
5,529,615
ALB icon
205
Albemarle
ALB
$15.1B
$270M 0.09%
+4,486,548
New +$264M
MOG.A icon
206
Moog Inc Class A
MOG.A
$13.6B
$262M 0.09%
3,545,232
-582,258
-14% -$42.1M
V icon
207
Visa
V
$671B
$262M 0.09%
4,000,000
LGF
208
DELISTED
Lions Gate Entertainment
LGF
$260M 0.09%
8,119,500
-50,000
-0.6% -$1.63M
TRMB icon
209
Trimble
TRMB
$13.1B
$260M 0.09%
9,793,300
+2,276,800
+30% +$64.2M
BCE icon
210
BCE
BCE
$21.6B
$259M 0.09%
+5,640,000
New +$253M
NSC icon
211
Norfolk Southern
NSC
$75.3B
$254M 0.09%
2,312,800
+79,000
+4% +$8.66M
FNSR
212
DELISTED
Finisar Corp
FNSR
$242M 0.08%
12,464,258
+4,312,495
+53% +$74M
NTES icon
213
NetEase
NTES
$79.5B
$240M 0.08%
12,127,865
-11,602,635
-49% -$222M
PPO
214
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$239M 0.08%
5,089,100
MBT
215
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$237M 0.08%
32,968,368
-7,657,324
-19% -$92M
VALE.P
216
DELISTED
Vale S A
VALE.P
$236M 0.08%
32,474,796
+29,324,796
+931% +$238M
TMH
217
DELISTED
Team Health Holdings Inc
TMH
$236M 0.08%
4,093,912
+571,647
+16% +$32.9M
OPLN
218
Openlane
OPLN
$4.34B
$234M 0.08%
17,835,085
+1,084,805
+6% +$13.1M
NVS icon
219
Novartis
NVS
$290B
$233M 0.08%
2,806,802
ZBRA icon
220
Zebra Technologies
ZBRA
$17.9B
$230M 0.08%
2,967,630
TSLA icon
221
Tesla
TSLA
$1.29T
$229M 0.08%
15,477,000
-720,000
-4% -$11.3M
SBNY
222
DELISTED
Signature Bank
SBNY
$229M 0.08%
1,816,559
+162,000
+10% +$19.3M
J icon
223
Jacobs Solutions
J
$17B
$228M 0.08%
6,165,747
+1,233,149
+25% +$47M
KITE
224
DELISTED
Kite Pharma, Inc.
KITE
$222M 0.08%
3,857,147
+1,467,962
+61% +$61.8M
ANET icon
225
Arista Networks
ANET
$265B
$220M 0.07%
57,977,568
+39,428,304
+213% +$183M

Similar funds

Capital Research Global Investors's Q4 2014 Portfolio in Review

As of Q4 2014, Capital Research Global Investors held 466 positions worth $295B, up 2% from $289B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Capital Research Global Investors's Q4 2014 filing shows 25 new, 139 increased, 121 reduced and 25 closed positions. Its largest new stake was Express Scripts Holding Company: 5,069,483 shares worth $429M. The largest sale was Gilead Sciences, an estimated $2.53B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

  • Capital Research Global Investors's largest Q4 2014 buy was Express Scripts Holding Company: 5,069,483 shares worth $429M.
  • Capital Research Global Investors added most to Digital Realty Trust in Q4 2014, an estimated $5.07B increase.
  • Capital Research Global Investors's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $2.53B.
  • Capital Research Global Investors fully exited Yum! Brands in Q4 2014, selling an estimated $315M.
  • Capital Research Global Investors's ten largest holdings make up 26% of its $295B portfolio in Q4 2014.
  • Capital Research Global Investors opened 25 new positions and closed 25 in Q4 2014.
  • Capital Research Global Investors's portfolio value rose 2% quarter-over-quarter to $295B.

Based on Capital Research Global Investors's 13F filing for Q4 2014, filed 13 Feb 2015.